* Q2 revenue 15.3 million Norwegian crowns ($1.86 million) versus 11.5 million crowns year ago [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: crowns, million, year ago, versus, million), Norwegian, revenue, widens, EBITDA, Pharmacon, BRIEF-Biotec
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/tksJqLn_juk/idUSL8N1AY0HW
* Signs supply agreement for Woulgan with first homecare provider in Germany
[ reuters.com ] rbssHealthcareNews,* Receives confirmation of Woulgan being reimbursed by Statutory Health Insurance fund (krankenkasse) in another region in Germeny
[ reuters.com ] rbssHealthcareNews,* Enters into distribution agreement for Woulgan with the German distributor Rogg Verbandstoffe GmbH
[ reuters.com ] rbssHealthcareNews,* Q1 revenue 17.3 million Norwegian crowns ($2.11 million)versus 12.3 million crowns year ago
[ reuters.com ] rbssHealthcareNews,* ArcticZymes, a subsidiary of Biotec Pharmacon has received 460,000 euros ($523,388.00) over the next four years in a project funded by the European Framework Programme for Research and Innovation, Horizon 2020 Source text for Eikon:
[ reuters.com ] rbssHealthcareNews,
